Caribou Biosciences
Linh Chu, PMP (she/her) has a strong background in regulatory operations, with experience working in various roles and companies. Linh is currently serving as the Senior Director of Regulatory Operations at Caribou Biosciences since 2019. Prior to this, Linh worked as the Director of Regulatory Operations at Caribou Biosciences from 2019 to 2023. Before joining Caribou Biosciences, they held positions at Intarcia Therapeutics, Inc. and Dynavax Technologies. At Intarcia Therapeutics, Inc., Linh worked as the Associate Director of Regulatory Operations from 2015 to 2019, and earlier as the Sr. Manager of Regulatory Operations from 2014 to 2015. At Dynavax Technologies, they served as the Manager of Regulatory Operations from 2012 to 2014, and earlier as the Associate Manager of Regulatory Operations from 2010 to 2012. Linh began their career at Dynavax Technologies Corporation as an Associate Project Manager from 2008 to 2010.
Linh Chu, PMP, obtained a Bachelor of Science degree in Business Management from San Francisco State University in 2002. Linh also holds a Certification in Project Management from the University of California, Berkeley. In addition, they have received Certificates in Project Human Resource Management and Regulatory Affairs from the same institution. Linh Chu is also a certified Project Management Professional.
Caribou Biosciences
2 followers
Caribou Biosciences is a leading clinical-stage CRISPR genome editing biotechnology company founded by pioneers of CRISPR biology and located in Berkeley, CA. The company is developing an internal pipeline of off-the-shelf, genome-edited CAR-T and natural killer (NK) cell therapies.